SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
简单的水杯
Lv1
50 积分
2024-01-15 加入
最近求助
最近应助
互助留言
Lipid Disorders in Uremia and Dialysis
1个月前
已完结
[A randomized controlled trial of indobufen versus aspirin in the prevention of bridging restenosis after coronary artery bypass grafting]
1个月前
已完结
Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease
2个月前
已完结
[A randomized controlled trial of indobufen versus aspirin in the prevention of bridging restenosis after coronary artery bypass grafting]
2个月前
已关闭
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial
2个月前
已完结
Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke
2个月前
已完结
Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
3个月前
已完结
Efficacy and Safety of Alirocumab and Evolocumab as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis
4个月前
已完结
Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits
4个月前
已完结
没有进行任何应助
感谢
1个月前
感谢
1个月前
感谢
2个月前
不找了【积分已退回】
2个月前
点赞
2个月前
谢谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论